Menu Search
Equities

Genus PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GNSN:MEX

Genus PLC

Actions
  • Price (MXN)602.66
  • Today's Change-115.50 / -16.08%
  • Shares traded--
  • 1 Year change--
  • Beta1.3925
Data delayed at least 20 minutes, as of Feb 10 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Genus plc is a United Kingdom-based global animal genetics company. The Company is advancing animal breeding and genetic improvement by applying biotechnology and selling added value products to livestock farming and food producers. It focuses on the dairy, beef and pork food production sectors, through two businesses: ABS (bovine genetics) and PIC (porcine genetics). Its segments include Genus PIC, Genus ABS and Genus Research and Development. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. Its porcine and bovine divisions operate under the brand names PIC and ABS. It operates in 30 countries, across six continents, and reaches a further 50 markets through distribution partners.

  • Revenue in GBP (TTM)672.80m
  • Net income in GBP19.30m
  • Incorporated1994
  • Employees3.17k
  • Location
    Genus PLCMatrix House, Basing ViewBASINGSTOKE RG21 4DZUnited KingdomGBR
  • Phone+44 125 634 7100
  • Fax+44 125 647 7385
  • Websitehttps://www.genusplc.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.